Device Trial Radar · NCT06681350
Occyo Tele-ophthalmology Study
Last checked: Nov 20, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
365
Actual
Start
Oct 15, 2024
Primary completion
Jun 19, 2026
Study completion Jun 19, 2026
Sponsor
- Lead sponsor
- Medical University InnsbruckAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 8, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 50 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The prospective, (observer) blinded clinical trial at the University Hospital for Ophthalmology includes patients routinely scheduled for cataract surgery at the Medical University of Innsbruck. Patients are enrolled one week prior to their planned cataract surgery. The participants will undergo a screening in which, in addition to the ophthalmological standard examinations, Occyo One images of the anterior segment of the eye are taken. After surgery, a post-operative follow-up visit takes place and a second set of Occyo One images will be generated. During the postoperative check-up, the study team at the trial center decides-based on defined criteria (medical history, slit lamp examination results)-whether a change in the subsequent patient management is necessary due to the presence of postoperative complications (unexpected management changes = UMC). Up on completion of all patient visits/study-specific measurements and data collection, information regarding diagnostic criteria and the Occyo One images are sent to an external, blinded ophthalmologist for telemedical assessment. Based on the available information and images, the blinded ophthalmologist decides whether a change in patient management should have been made or not. The difference in the detection of an event resulting in a UMC is the primary objective of this clinical investigation.
Conditions
- Cataract
Interventions
Ocular surface imagingDevice
Telemedical examination of high-resolution, all-in-focus images of the cornea, sclera, conjunctiva, and lid margins for montioring of postoperative complications
Primary outcomes
What the sponsor says the trial is designed to measure.
- Unexpected Management ChangesTime frame: 1 week
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medical University Innsbruck, University Hospital for Ophthalmology and Optometry
Innsbruck, Austria
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.